Join Top Biopharma Experts Advancing HPAPI & ADC Science

Gain actionable insights on bioconjugation, lyophilization, and analytical science — plus a facility tour and live case studies. Exchange ideas and explore new technologies shaping the future of ADC and HPAPI innovation.

Join experts from Biopharma Group and Fleet Bioprocessing for a focused one-day symposium exploring the latest advances in antibody drug conjugate (ADC) and highly potent API (HPAPI) development.

Sessions cover bioconjugation, freeze-drying, and analytical characterisation, complemented by roundtable discussions and our Winchester facility tour.

Attendees will gain fresh insights into:

• Market trends
• Up and downstream bioprocessing
• Formulation optimisation
• Freeze-drying techniques
• Analytical control strategies

All illustrated through real-world case studies and interactive Q&A sessions.

25th February, 2025

9AM to 5PM

Winchester, United Kingdom

Biopharma Group House

Starting from £90

See pricing options

Attendance

£90

This option provides access to the symposium.

Freeze-drying microscopy (non-cytotoxic product) + attendance

£380

A spot at the event and a non-cytotoxic FDM analysis of your product.

Freeze-drying microscopy (cytotoxic product) + attendance

£480

A spot at the event and a cytotoxic FDM analysis of your product.

In addition to attendance to the symposium, we offer an option to analyse your product* using our freeze-drying microscope - Lyostat 5. Results of the analysis will be presented during Session 4 (see agenda below).

To book an freeze-drying microscopy analysis using Lyostat 5 send over your product specifications at time of booking.

*Lyostat analysis is subject to risk assessment based on receiving the material safety data sheet beforehand.

This event is designed for professionals specialising in:

• Bioconjugation
• Process Development
• Analytical Sciences
• Regulatory Affairs

Kevin Ward PhD

Director of R&D, Biopharma Group

Kevin Ward entered the world of freeze-drying in 1993 when he embarked on a PhD in lyophilisation of proteins and liposomes. After working in the pharmaceutical industry and vaccine development, he joined Biopharma Group in 2000. As R&D Director, Kevin has built up a team of dedicated freeze-drying scientists, worked on over 4000+ projects for more than 500 client companies across the globe, developed 3 analytical instruments, run more than 400 training courses, and successfully secured funding for numerous research projects.

Alastair Dent FRSC

Owner, Fleet Bioprocessing

Alastair has worked in the field of antibody chemistry for over 40 years, working for Amersham International, Kodak and Johnson & Johnson before founding Fleet Bioprocessing Ltd. in 2000 as a CDMO specialising in this field. He has written major reference works on bioconjugation as well as numerous published articles on this and related subjects. As well as being Fleet’s Managing Director, he regularly acts as a process 4development consultant and is a former chair of the Royal Society of Chemistry’s Analytical Biosciences Group.

Chris Blencowe MChem PhD MRSC

Chemistry Director, Fleet Bioprocessing

Chris has 18 years of (bio)conjugation experience, stemming from a Chemistry PhD at Reading, where he invented a novel pH-sensitive self-immolative linker for controlled release applications. He has published several articles in this field including a featured review for Polymer Chemistry. Previously he worked at Unilever on various controlled release technologies and in 2013 joined Fleet Bioprocessing Ltd, applying this experience to bioconjugation and the development of antibody-drug conjugates, currently acting as Fleet’s Chemistry Director since 2020.

Biopharma Group is the UK-based expert in the field of lyophilisation. We provide comprehensive CDMO services from R&D and consultancy solutions for lyophilized and liquid formulations, to pre-clinical and aseptic fill-finish clinical manufacturing for the pharmaceutical, diagnostic and biotech industries, from start-ups to industry giants.

We also host training courses, seminars and webinars in the field of lyophilisation. For more information about other courses, please visit our website.

Have a question? Contact us here.

Fleet Bioprocessing Ltd. are a CDMO based in Hampshire, UK, with 25 years of expertise in several fields linked largely by their use of antibodies and related reagents.

These include the development of antibody-drug conjugates for therapeutic use, labelled antibodies for a wide variety of diagnostic applications and immunoassays (ELISAs) for the detection of clinically relevant molecules and to support clinical trials for new drug candidates. Fleet are certified to ISO9001: 2015 and ISO13485: 2016 and are widely recognised as offering world-class skills in these fields, based on the experience gained by its technical leaders in companies such as GSK, Unilever and Johnson & Johnson. 

biopharmagroupcdmo.com